BELLICUM PHARMACEUTICALS, INC Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2023.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the quarter ending September 30, 2023 was -$773K, a 89.2% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the twelve months ending September 30, 2023 was -$23.8M, a 3.7% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2022 was -$27M, a 8.51% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2021 was -$24.9M, a 51.9% increase from 2020.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2020 was -$51.7M, a 40.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$23.8M -$773K +$6.39M +89.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$30.2M -$7.07M -$530K -8.11% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$29.7M -$8.65M -$2.71M -45.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$27M -$7.34M -$2.24M -43.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$24.7M -$7.17M -$4.12M -135% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$20.6M -$6.54M +$1.25M +16.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$21.9M -$5.94M +$3M +33.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$24.9M -$5.1M +$7.91M +60.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$32.8M -$3.04M +$9.26M +75.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$42M -$7.79M +$3.97M +33.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$46M -$8.94M +$5.68M +38.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$51.7M -$13M +$888K +6.39% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$52.6M -$12.3M +$11.1M +47.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$63.7M -$11.8M +$14.4M +55.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$78.1M -$14.6M +$9.25M +38.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$87.4M -$13.9M +$12.7M +47.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$100M -$23.4M -$209K -0.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$99.8M -$26.2M -$2.59M -11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$97.2M -$23.9M -$1.76M -7.98% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$95.5M -$26.6M -$7.12M -36.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$88.3M -$23.2M -$523K -2.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$87.8M -$23.6M +$221K +0.93% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$88M -$22.1M -$655K -3.05% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$87.4M -$19.4M +$68K +0.35% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$87.5M -$22.7M -$5.28M -30.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$82.2M -$23.8M -$7.53M -46.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$74.6M -$21.4M -$6.27M -41.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$68.4M -$19.5M -$2.51M -14.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$65.9M -$17.4M -$3.81M -28% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$62.1M -$16.3M -$5.55M -51.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$56.5M -$15.2M -$7.37M -94.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$49.1M -$17M +$32.4M +65.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-13
Q3 2015 -$81.5M -$13.6M -$10.7M -370% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-13
Q2 2015 -$70.8M -$10.7M -$7.43M -227% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-13
Q1 2015 -$63.4M -$7.81M -$5.53M -243% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-13
Q4 2014 -$57.8M -$49.4M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$2.9M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$3.27M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$2.28M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.